NI
GSK icon

Nepsis Inc’s GSK GSK Stock Holding History

Nepsis Inc’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-18,015
Closed -$980K – 33
2022
Q2 		$980K Sell
18,015
-51
-0.3% -$2.81K 0.33% 30
2022
Q1 		$984K Buy
+18,066
New +$981K 0.29% 31
2021
Q4 		– Sell
-18,272
Closed -$873K – 31
2021
Q3 		$873K Sell
18,272
-66
-0.4% -$3.31K 0.28% 29
2021
Q2 		$913K Buy
18,338
+24
+0.1% +$1.15K 0.29% 28
2021
Q1 		$817K Buy
18,314
+1,025
+6% +$46.5K 0.26% 30
2020
Q4 		$795K Sell
17,289
-119,223
-87% -$5.48M 0.29% 31
2020
Q3 		$6.42M Buy
136,512
+54,674
+67% +$2.74M 3.08% 21
2020
Q2 		$4.17M Buy
81,838
+36,658
+81% +$1.88M 2.02% 24
2020
Q1 		$2.14M Buy
+45,180
New +$2.41M 1.43% 24

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Nepsis Inc's GSK Position: Q3 2022 in Review

Nepsis Inc sold out of GSK (GSK) in Q3 2022, closing a stake of 18,015 shares — an estimated $980K sold.

Nepsis Inc first reported a position in GSK in Q1 2020 and held it in 9 quarters. The position peaked at $6.42M in Q3 2020. 743 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Nepsis Inc reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • Nepsis Inc sold 18,015 GSK shares in Q3 2022, an estimated $980K.
  • Nepsis Inc first reported a position in GSK in Q1 2020 and held it in 9 quarters.
  • Nepsis Inc's GSK position peaked at $6.42M in Q3 2020.
  • 743 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Nepsis Inc's 13F filing for Q3 2022, filed 1 Nov 2022.